| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 111 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2019 | Mann Michael Scott | President | Buy | 22,000 | $0.02 | $414.00 | - | |
| Mar 21, 2019 | Collier Alan Brian | CEO | Buy | 43,000 | $0.02 | $826.65 | - | |
| Mar 18, 2019 | Collier Alan Brian | CEO | Buy | 54,500 | $0.02 | $1,098.65 | - | |
| Mar 15, 2019 | Mann Michael Scott | President | Buy | 2,000 | $0.02 | $42.00 | - | |
| Mar 12, 2019 | Collier Alan Brian | CEO | Buy | 21,000 | $0.02 | $413.05 | - | |
| Mar 12, 2019 | Mann Michael Scott | President | Buy | 56,000 | $0.02 | $1,151.40 | - | |
| Mar 7, 2019 | Collier Alan Brian | CEO | Buy | 103,500 | $0.02 | $2,039.65 | - | |
| Mar 4, 2019 | Collier Alan Brian | CEO | Buy | 46,500 | $0.02 | $965.95 | - | |
| Feb 26, 2019 | Collier Alan Brian | CEO | Buy | 40,000 | $0.02 | $889.30 | - | |
| Feb 21, 2019 | Collier Alan Brian | CEO | Buy | 50,000 | $0.02 | $1,159.00 | - |